KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation & Amortization (CF) (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Depreciation & Amortization (CF) data on record, last reported at $78.3 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 23.34% year-over-year to $78.3 million; the TTM value through Dec 2025 reached $403.3 million, up 11.49%, while the annual FY2025 figure was $403.3 million, 11.49% up from the prior year.
  • Depreciation & Amortization (CF) reached $78.3 million in Q4 2025 per CRL's latest filing, down from $85.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $120.4 million in Q1 2025 and bottomed at $61.5 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $82.4 million, with a median of $78.0 million recorded in 2023.
  • The widest YoY moves for Depreciation & Amortization (CF): up 41.01% in 2025, down 23.34% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $67.2 million in 2021, then grew by 15.32% to $77.5 million in 2022, then grew by 3.83% to $80.5 million in 2023, then grew by 26.82% to $102.1 million in 2024, then fell by 23.34% to $78.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $78.3 million in Q4 2025, $85.2 million in Q3 2025, and $119.5 million in Q2 2025.